[2-[[5-(1,5-dihydrotriazol-2-yl)-2-pyridinyl]methyl]-1,3-oxazol-4-yl]-[3-hydroxy-2-(trifluoromethyl)azetidin-1-yl]methanone

C16H15F3N6O3 — CID 176989632

IUPAC[2-[[5-(1,5-dihydrotriazol-2-yl)-2-pyridinyl]methyl]-1,3-oxazol-4-yl]-[3-hydroxy-2-(trifluoromethyl)azetidin-1-yl]methanone
SMILESO=C(c1coc(Cc2ccc(N3N=CCN3)cn2)n1)N1CC(O)C1C(F)(F)F
InChIInChI=1S/C16H15F3N6O3/c17-16(18,19)14-12(26)7-24(14)15(27)11-8-28-13(23-11)5-9-1-2-10(6-20-9)25-21-3-4-22-25/h1-3,6,8,12,14,22,26H,4-5,7H2
InChIKeyHJLKYPCEWXGJMW-UHFFFAOYSA-N
MW396.33 g/mol
LogP0.72
Rot. Bonds4

About [2-[[5-(1,5-dihydrotriazol-2-yl)-2-pyridinyl]methyl]-1,3-oxazol-4-yl]-[3-hydroxy-2-(trifluoromethyl)azetidin-1-yl]methanone

[2-[[5-(1,5-dihydrotriazol-2-yl)-2-pyridinyl]methyl]-1,3-oxazol-4-yl]-[3-hydroxy-2-(trifluoromethyl)azetidin-1-yl]methanone (PubChem CID 176989632) has the molecular formula C16H15F3N6O3 and a molecular weight of 396.33 g/mol. Its IUPAC name is [2-[[5-(1,5-dihydrotriazol-2-yl)-2-pyridinyl]methyl]-1,3-oxazol-4-yl]-[3-hydroxy-2-(trifluoromethyl)azetidin-1-yl]methanone.

Molecular Properties

Compound Name[2-[[5-(1,5-dihydrotriazol-2-yl)-2-pyridinyl]methyl]-1,3-oxazol-4-yl]-[3-hydroxy-2-(trifluoromethyl)azetidin-1-yl]methanone
PubChem CID176989632
Molecular FormulaC16H15F3N6O3
Molecular Weight396.33 g/mol
Exact Mass396.12
IUPAC Name[2-[[5-(1,5-dihydrotriazol-2-yl)-2-pyridinyl]methyl]-1,3-oxazol-4-yl]-[3-hydroxy-2-(trifluoromethyl)azetidin-1-yl]methanone
SMILESO=C(c1coc(Cc2ccc(N3N=CCN3)cn2)n1)N1CC(O)C1C(F)(F)F
InChIInChI=1S/C16H15F3N6O3/c17-16(18,19)14-12(26)7-24(14)15(27)11-8-28-13(23-11)5-9-1-2-10(6-20-9)25-21-3-4-22-25/h1-3,6,8,12,14,22,26H,4-5,7H2
InChIKeyHJLKYPCEWXGJMW-UHFFFAOYSA-N
XLogP0.72
TPSA107.09 Ų
H-Bond Donors2
H-Bond Acceptors8
Rotatable Bonds4
Heavy Atoms28
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500396.33
LogP ≤ 50.72
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 108

Analyze [2-[[5-(1,5-dihydrotriazol-2-yl)-2-pyridinyl]methyl]-1,3-oxazol-4-yl]-[3-hydroxy-2-(trifluoromethyl)azetidin-1-yl]methanone with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of [2-[[5-(1,5-dihydrotriazol-2-yl)-2-pyridinyl]methyl]-1,3-oxazol-4-yl]-[3-hydroxy-2-(trifluoromethyl)azetidin-1-yl]methanone?
The IUPAC name of [2-[[5-(1,5-dihydrotriazol-2-yl)-2-pyridinyl]methyl]-1,3-oxazol-4-yl]-[3-hydroxy-2-(trifluoromethyl)azetidin-1-yl]methanone (CID 176989632) is [2-[[5-(1,5-dihydrotriazol-2-yl)-2-pyridinyl]methyl]-1,3-oxazol-4-yl]-[3-hydroxy-2-(trifluoromethyl)azetidin-1-yl]methanone.
What is the SMILES notation for [2-[[5-(1,5-dihydrotriazol-2-yl)-2-pyridinyl]methyl]-1,3-oxazol-4-yl]-[3-hydroxy-2-(trifluoromethyl)azetidin-1-yl]methanone?
The canonical SMILES for [2-[[5-(1,5-dihydrotriazol-2-yl)-2-pyridinyl]methyl]-1,3-oxazol-4-yl]-[3-hydroxy-2-(trifluoromethyl)azetidin-1-yl]methanone is O=C(c1coc(Cc2ccc(N3N=CCN3)cn2)n1)N1CC(O)C1C(F)(F)F.
What is the InChIKey of [2-[[5-(1,5-dihydrotriazol-2-yl)-2-pyridinyl]methyl]-1,3-oxazol-4-yl]-[3-hydroxy-2-(trifluoromethyl)azetidin-1-yl]methanone?
The InChIKey is HJLKYPCEWXGJMW-UHFFFAOYSA-N. The full InChI is InChI=1S/C16H15F3N6O3/c17-16(18,19)14-12(26)7-24(14)15(27)11-8-28-13(23-11)5-9-1-2-10(6-20-9)25-21-3-4-22-25/h1-3,6,8,12,14,22,26H,4-5,7H2.
What are the key properties of [2-[[5-(1,5-dihydrotriazol-2-yl)-2-pyridinyl]methyl]-1,3-oxazol-4-yl]-[3-hydroxy-2-(trifluoromethyl)azetidin-1-yl]methanone?
[2-[[5-(1,5-dihydrotriazol-2-yl)-2-pyridinyl]methyl]-1,3-oxazol-4-yl]-[3-hydroxy-2-(trifluoromethyl)azetidin-1-yl]methanone has a molecular weight of 396.33 g/mol, XLogP of 0.72, 4 rotatable bonds, 2 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for [2-[[5-(1,5-dihydrotriazol-2-yl)-2-pyridinyl]methyl]-1,3-oxazol-4-yl]-[3-hydroxy-2-(trifluoromethyl)azetidin-1-yl]methanone is sourced from PubChem (CID 176989632), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).